Fiducial Markers Market
Fiducial Markers Market Analysis By Product Type (Polymer-based, Metal-based, Liquid-based), By Modality (Tomotherapy, Cyberknife), By Disease Site (Head & Neck, Breast, Lung or Other Gynaecological Organs), By End User (Hospitals, Radiotherapy Centers) - Global Insights 2032
Analysis of Fiducial Markers market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Fiducial Markers Market Outlook (2022 to 2032)
The global fiducial markers market is set to reach US$ 138.7 million in 2022 and further expand at a CAGR of 7.9% to end up at a market valuation of US$ 295.6 million by 2032.
Pure gold markers lead the race and are anticipated to contribute more than 55% share of the global market during the forecast period (2022 to 2032).
| Report Attributes | Details |
|---|---|
| Fiducial Markers Market Size (2021A) | US$ 126.2 Million |
| Estimated Market Value (2022E) | US$ 138.7 Million |
| Forecasted Market Value (2032F) | US$ 295.6 Million |
| Global Market Growth Rate (2022 to 2032) | 7.9% CAGR |
| North America Market Share (2021) | ~ 27.8% |
| Europe Market Growth Rate (2022 to 2032) | ~ 6.8% CAGR |
| United States Market Growth Rate (2022 to 2032) | ~ 6.2% CAGR |
| Market Share of Top 5 Companies | ~ 22.5% |
| Key Companies Profiled | Eckert & Ziegler BEBIG; Innovative Oncology Solutions; Boston Scientific; IBA Dosimetry; Best Medical International, Inc.; IZI Medical Products; Carbon Medical Technologies; CIVCO; alphaXRT |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Sales Analysis of Fiducial Markers (2017 to 2021) Vs. Market Forecasts (2022 to 2032)
Rising prevalence of various types of cancers among the global population has created a high requirement for the identification of tumors, which has generated a huge space for fiducial markers. Intensifying prevalence of tumors, cancer, and associated diseases led to the high acceptance of fiducial markers among radiotherapy centers, hospitals, cancer institutes, and others over the historical period (2017 to 2021), which amplified the sales of fiducial markers at a CAGR of 10.3%.
Moreover, rising awareness regarding the early detection of cancer and proper treatment of radiotherapy will further fuel the sales of fiducial markers during the forecast period. Manufacturers are also focusing on enhancing the variety of fiducial markers, which will increase their demand across the globe.
Fact.MR predicts that the global fiducial markers market will be valued at US$ 295.6 million by the end of 2032, expanding at a CAGR of 7.9%.
- Short Term (2022 to 2025): Rising prevalence of cancer across the world will spur the sales of fiducial markers during the early forecast period.
- Medium Term (2025 to 2028): Government initiatives to control cancer and related diseases are anticipated to fuel the demand for fiducial markers from 2025 to 2028.
- Long Term (2028 to 2032): Product development and availability of a variety of fiducial markers in various sizes will generate long-term sales.
Market share analysis of fiducial markers based on product type and region. Under the product type segment, pure gold markers dominate with 62.8% market share in 2022.
Why is the Importance of Fiducial Markers Rising Rapidly?
“Intensifying Prevalence of Various Cancers Led to Upsurge in Sales of Fiducial Markers’’
Growing prevalence of various cancers such as lung cancer, breast cancer, and prostate cancer is expected to drive the demand growth for fiducial markers over the forecast period. In recent years, demand for non-invasive procedures, and radiation therapies for cancers, such as prostate cancer, has increased significantly.
Moreover, patients suffering from cancer, especially in developed regions, are progressively being treated with radiation therapies with fiducial marker placement for the particular positioning of the therapy and better and improved results post-procedure.
- As per the National Cancer Institute, cancer is one of the leading causes contributing to the high mortality rate globally. There were approximately 19.3 million new cancer cases and 9.9 million cancer-related deaths worldwide, in 2021.
Moving cancer forms such as prostate cancer and lung cancer have a high demand for fiducial marker placement before radiation therapy. The moving organs pose a high threat of improper treatment, leading to lower efficiency of the results. Increase in the prevalence of these cancers is expected to boost the growth of the fiducial markers market over the coming years.
“Growing Adoption of Radiotherapy Devices by Oncologists and Rising Demand for IGRT and SBRT Procedures”
Radiation treatment plays an extremely vital role in the management and treatment of cancer. Over the recent years, this approach has become highly contained with technological advancements and has doubled the need for radiotherapy during the last 10 years.
More than 50% of all cancer patients are expected to get radiotherapy throughout the treatment of their disease, either for symptom control or in primary management. This approach has further ensured the usage of radiotherapy fields that promise the proper treatment of tumors and the capability to heighten the radiation dose with subsequently developed outcomes and minimum toxicity.
Modern radiotherapy devices are high in demand for the irradiation procedures of organs that are not stable in position. Ensuring the exact positioning of the target structure that needs to be radiated before or during the treatment requires constant image guidance by X-ray radiography (image-guided radiotherapy IGRT) or computed tomography (CT).
Thus, due to certain combinations of novel irradiation imaging and devices, such as in-room CT or onboard imaging, tomotherapy systems are developed and are high in demand.
- The Massachusetts General Hospital (MGH) developed a system called the IRIS System that provides videos that are fluoroscopic during the entire treatment. IRIS consists of a tracking system that is capable of tracking multiple implanted markers.
The development of novel systems capable of tracking fiducial markers for tumors in moving organs is expected to boost market growth during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Market Expansion Being Dented to Some Extent?
“High Risk of Complications Associated with Fiducial Marker Placements”
The use of fiducial markers has helped in pointing the position of tumors to deliver maximum dosage while minimizing the dose delivery to the surrounding healthy tissue. Though this has proved to be of great advantage in radiation therapy procedures, there are also certain complications that fiducial markers carry.
Fiducial markers are supposed to be fixed at a particular target, however, they might move away from the originally placed position where they were implanted. A long period is required in between the implantation of markers and for them to hold the position and stabilize.
Certain risks are associated with the use of fiducial markers. Fiducial markers, when placed or used for lung cancer treatment, might lead to a complication called collapsed lung or pneumothorax. In this condition, the surgeon is required to insert a chest tube for removing the air pocket and further re-expand the lung.
Prostatitis is another complication associated with fiducial marker placement in the prostate. Approximately 32% of patients with fiducial marker implants have at least one symptom of prostatitis, i.e., fever or shivers, pain, dysuria, or frequency.
Any treatment procedure where the skin is needed to be penetrated carries a risk of infection. This possibility of infection requires antibiotic treatments. These factors are expected to hamper the growth of the fiducial markers market to some extent.
Country-wise Insights
Will Rise in Radiation Therapy in the U.S. Drive High Demand for Fiducial Markers?
The fiducial markers market in the U.S. is expected to expand at a CAGR of 6.2% from 2022 to 2032.
The dominance of the U.S. is because of a high number of radiotherapy centers, cancer institutes, and extremely developed manufacturing units. It has been observed that radiation therapy centers are rapidly rising in number due to a high number of cancer cases.
- Recently, the partnership between the National Cancer Institute (NCI) with the National Institutes of Health (NHI) is providing efficient treatment to the growing number of cancer patients in the United States.
Why is China a Highly Opportunistic Market for Fiducial Marker Manufacturers?
China has made significant advancements in the detection and treatment of several types of cancer. Manufacturers of fiducial markers have benefited immensely due to the integration of cutting-edge technologies in radiation meant for cancer.
Over the next few years, demand for fiducial markers is likely to rise as more cancer patients turn to correct treatment at an earlier stage. Hence, following these factors, China will become a highly lucrative market for fiducial marker manufacturers.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Fiducial Marker is Most Widely Used across the World?
The fiducial markers market, under product type, is categorized into polymer-based markers, metal-based markers, pure gold markers, and liquid-based markers. Amongst them, pure gold fiducial markers held the largest market share of 63.1% in 2021 and are expected to witness a CAGR of 7.5% during the forecast years of 2022 to 2032.
Pure gold fiducial markers have gained high popularity among all the markers and are expected to hold this position during the forecast period. Intraprostatic gold fiducial markers ensure that highly accurate and precise image-guided radiation therapy can be administered to patients suffering from prostate cancer. These are also highly preferred by radiologists in treating lung, breast, and other types of cancers.
Patients with prostate cancer receive extremely accurate and precise image-guided radiation therapy with the use of intraprostatic gold fiducial markers.
Why Has Photon Therapy Gained Wide Prominence in the Fiducial Markers Market?
In terms of modality, the market is segmented into photon therapy, proton therapy, tomotherapy, and cyberknife. Out of these, the photon therapy segment holds a majority of the share in the global market. It is anticipated to follow the same trend during the forecast period. The segment is projected to account for 50.8% share of the market by 2032.
The dominance of photon therapy is due to its high demand from varied end-users such as radiotherapy centers, hospitals, and others. Photon therapy attacks tumors by preventing cancer cells from growing and dividing, and hence, it is highly desirable due to its efficiency.
Competitive Landscape
Prominent fiducial marker manufacturers are Eckert & Ziegler BEBIG, Innovative Oncology Solutions, Boston Scientific, IBA Dosimetry, Best Medical International, Inc., IZI Medical Products, Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S, and Stellar Medical.
Most companies producing fiducial markers are working towards expanding their product portfolios. However, the most significant approach towards increasing the customer pool is through the marketing of the product through online portals. Making the product available on online channels is also expected to drive the growth of the market.
- In 2020, Innovative Oncology Solutions launched its new range of fiducial markers - SBRT Immobilization, Supine Breast & Thorax Positioning, and others.
- In 2020, CIVCO launched its new extensive range of fiducial markers - such as Solstice™ MR SRS Immobilization System, Monarch™ Vac-Lok™ Options, and others.
Fact.MR has provided detailed information about the price points of key manufacturers of fiducial markers positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Fiducial Marker Industry Research
-
By Product Type :
- Polymer-based Markers
- Metal-based Markers
- Pure Gold Markers
- Liquid-based Markers
-
By Modality :
- Photon Therapy
- Proton Therapy
- Tomotherapy
- Cyberknife
-
By Disease Site :
- Head & Neck
- Breast
- Lung
- Abdomen
- Prostate
- Kidney
- Cervix or Other Gynaecologic Organs
-
By End User :
- Hospitals
- Cancer Research Institutes
- Radiotherapy Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Table of Content
- 1. Market - Executive Summary
- 2. Market Overview
- 3. Market Background and Foundation Data
- 4. Global Market Value (US$ Million) Analysis and Forecast
- 5. Global Market Analysis and Forecast, By Product Type
- 5.1. Polymer Based Markers
- 5.2. Metal Based Markers
- 5.3. Pure Gold Markers
- 5.4. Liquid Based Markers
- 6. Global Market Analysis and Forecast, By Modality
- 6.1. Photon Therapy
- 6.2. Proton Therapy
- 6.3. Tomotherapy
- 6.4. Cyberknife
- 7. Global Market Analysis and Forecast, By Disease Site
- 7.1. Head & Neck
- 7.2. Breast
- 7.3. Lung
- 7.4. Abdomen
- 7.5. Prostate
- 7.6. Kidney
- 7.7. Cervix or other gynaecologic organs
- 8. Global Market Analysis and Forecast, By End User
- 8.1. Hospitals
- 8.2. Cancer Research Institutes
- 8.3. Radiotherapy Centers
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & ASEAN
- 9.6. Oceania
- 9.7. Middle East & Africa
- 10. North America Market Analysis and Forecast
- 11. Latin America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia & ASEAN Market Analysis and Forecast
- 15. Oceania Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Country-level Market Analysis and Forecast
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Eckert & Zieglar BEBIG
- 19.2. Innovative Oncology Solutions
- 19.3. Boston Scientific
- 19.4. IBA
- 19.5. Best Medical International, Inc.
- 19.6. IZI Medical Products
- 19.7. Carbon Medical Technologies
- 19.8. CIVCO
- 19.9. AlphaXRT
- 19.10. Nanovi A/S
- 19.11. Stellar Medical
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (USD Million) and Forecast by Region, 2017 to 2021
Table 02: Global Market Value (USD Million) and Forecast by Region, 2022 to 2032
Table 03: Global Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 04: Global Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 05: Global Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 06: Global Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 07: Global Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 08: Global Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 09: Global Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 10: Global Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 11: North America Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 12: North America Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 13: North America Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 14: North America Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 15: North America Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 16: North America Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 17: North America Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 18: North America Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 19: North America Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 20: North America Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 21: Latin America Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 22: Latin America Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 23: Latin America Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 24: Latin America Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 25: Latin America Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 26: Latin America Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 27: Latin America Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 28: Latin America Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 29: Latin America Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 30: Latin America Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 31: Europe Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 32: Europe Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 33: Europe Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 34: Europe Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 35: Europe Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 36: Europe Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 37: Europe Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 38: Europe Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 39: Europe Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 40: Europe Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 41: East Asia Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 42: East Asia Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 43: East Asia Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 44: East Asia Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 45: East Asia Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 46: East Asia Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 47: East Asia Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 48: East Asia Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 49: East Asia Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 50: East Asia Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 51: South Asia & ASEAN Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 52: South Asia & ASEAN Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 53: South Asia & ASEAN Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 54: South Asia & ASEAN Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 55: South Asia & ASEAN Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 56: South Asia & ASEAN Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 57: South Asia & ASEAN Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 58: South Asia & ASEAN Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 59: South Asia & ASEAN Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 60: South Asia & ASEAN Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 61: Oceania Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 62: Oceania Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 63: Oceania Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 64: Oceania Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 65: Oceania Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 66: Oceania Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 67: Oceania Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 68: Oceania Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 69: Oceania Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 70: Oceania Market Value (USD Million) and Forecast by End User, 2022 to 2032
Table 71: MEA Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 72: MEA Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 73: MEA Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 74: MEA Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 75: MEA Market Value (USD Million) and Forecast by Modality, 2017 to 2021
Table 76: MEA Market Value (USD Million) and Forecast by Modality, 2022 to 2032
Table 77: MEA Market Value (USD Million) and Forecast by Disease Site, 2017 to 2021
Table 78: MEA Market Value (USD Million) and Forecast by Disease Site, 2022 to 2032
Table 79: MEA Market Value (USD Million) and Forecast by End User, 2017 to 2021
Table 80: MEA Market Value (USD Million) and Forecast by End User, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (USD Million) Forecast, 2022 to 2032
Figure 02: Global Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 03: Global Market Value (USD Million) by Region, 2022 & 2032
Figure 04: Global Market Y-o-Y Growth Rate by Region, 2022 to 2032
Figure 05: Global Market Value (USD Million) by Product Type, 2022 & 2032
Figure 06: Global Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 07: Global Market Value (USD Million) by Modality, 2022 & 2032
Figure 08: Global Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 09: Global Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 11: Global Market Value (USD Million) by End User, 2022 & 2032
Figure 12: Global Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 13: North America Market Value (USD Million) Forecast, 2022 to 2032
Figure 14: North America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 15: North America Market Value (USD Million) by Country, 2022 & 2032
Figure 16: North America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 17: North America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 19: North America Market Value (USD Million) by Modality, 2022 & 2032
Figure 20: North America Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 21: North America Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 22: North America Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 23: North America Market Value (USD Million) by End User, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 25: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 26: North America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 27: North America Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 28: North America Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 30: Latin America Market Value (USD Million) Forecast, 2022 to 2032
Figure 31: Latin America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 32: Latin America Market Value (USD Million) by Country, 2022 & 2032
Figure 33: Latin America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 34: Latin America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 35: Latin America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 36: Latin America Market Value (USD Million) by Modality, 2022 & 2032
Figure 37: Latin America Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 38: Latin America Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 39: Latin America Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 40: Latin America Market Value (USD Million) by End User, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 42: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 43: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 44: Latin America Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 46: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 47: Europe Market Value (USD Million) Forecast, 2022 to 2032
Figure 48: Europe Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 49: Europe Market Value (USD Million) by Country, 2022 & 2032
Figure 50: Europe Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 51: Europe Market Value (USD Million) by Product Type, 2022 & 2032
Figure 52: Europe Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 53: Europe Market Value (USD Million) by Modality, 2022 & 2032
Figure 54: Europe Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 55: Europe Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 56: Europe Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 57: Europe Market Value (USD Million) by End User, 2022 & 2032
Figure 58: Europe Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 59: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 60: Europe Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 61: Europe Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 62: Europe Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 63: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 64: East Asia Market Value (USD Million) Forecast, 2022 to 2032
Figure 65: East Asia Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 66: East Asia Market Value (USD Million) by Country, 2022 & 2032
Figure 67: East Asia Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 68: East Asia Market Value (USD Million) by Product Type, 2022 & 2032
Figure 69: East Asia Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 70: East Asia Market Value (USD Million) by Modality, 2022 & 2032
Figure 71: East Asia Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 72: East Asia Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 73: East Asia Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 74: East Asia Market Value (USD Million) by End User, 2022 & 2032
Figure 75: East Asia Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 76: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 78: East Asia Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 79: East Asia Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 81: South Asia & ASEAN Market Value (USD Million) Forecast, 2022 to 2032
Figure 82: South Asia & ASEAN Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 83: South Asia & ASEAN Market Value (USD Million) by Country, 2022 & 2032
Figure 84: South Asia & ASEAN Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 85: South Asia & ASEAN Market Value (USD Million) by Product Type, 2022 & 2032
Figure 86: South Asia & ASEAN Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 87: South Asia & ASEAN Market Value (USD Million) by Modality, 2022 & 2032
Figure 88: South Asia & ASEAN Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 89: South Asia & ASEAN Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 90: South Asia & ASEAN Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 91: South Asia & ASEAN Market Value (USD Million) by End User, 2022 & 2032
Figure 92: South Asia & ASEAN Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 93: South Asia & ASEAN Market Attractiveness Analysis by Country, 2022 to 2032
Figure 94: South Asia & ASEAN Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 95: South Asia & ASEAN Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 96: South Asia & ASEAN Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 97: South Asia & ASEAN Market Attractiveness Analysis by End User, 2022 to 2032
Figure 98: Oceania Market Value (USD Million) Forecast, 2022 to 2032
Figure 99: Oceania Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 100: Oceania Market Value (USD Million) by Country, 2022 & 2032
Figure 101: Oceania Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 102: Oceania Market Value (USD Million) by Product Type, 2022 & 2032
Figure 103: Oceania Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 104: Oceania Market Value (USD Million) by Modality, 2022 & 2032
Figure 105: Oceania Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 106: Oceania Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 107: Oceania Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 108: Oceania Market Value (USD Million) by End User, 2022 & 2032
Figure 109: Oceania Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 110: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 111: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 112: Oceania Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 113: Oceania Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 114: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 115: MEA Market Value (USD Million) Forecast, 2022 to 2032
Figure 116: MEA Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 117: MEA Market Value (USD Million) by Country, 2022 & 2032
Figure 118: MEA Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 119: MEA Market Value (USD Million) by Product Type, 2022 & 2032
Figure 120: MEA Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 121: MEA Market Value (USD Million) by Modality, 2022 & 2032
Figure 122: MEA Market Y-o-Y Growth Rate by Modality, 2022 to 2032
Figure 123: MEA Market Value (USD Million) by Disease Site, 2022 & 2032
Figure 124: MEA Market Y-o-Y Growth Rate by Disease Site, 2022 to 2032
Figure 125: MEA Market Value (USD Million) by End User, 2022 & 2032
Figure 126: MEA Market Y-o-Y Growth Rate by End User, 2022 to 2032
Figure 127: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 128: MEA Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 129: MEA Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 130: MEA Market Attractiveness Analysis by Disease Site, 2022 to 2032
Figure 131: MEA Market Attractiveness Analysis by End User, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What size is the market expected to reach by 2032?
Sales of fiducial markers are anticipated to reach US$ 295.6 million by 2032.
Which type of fiducial marker is most widely preferred?
Pure gold markers account for 62.8% share of the global market.
What is the current valuation of the global fiducial markers market?
The global fiducial markers market is valued at US$ 138.7 million in 2022.
Which regional market accounts for high revenue generation?
Europe leads the global market and accounts for 28.3% market share in 2022.
How fast did the market expand over the last four years?
From 2017 to 2021, worldwide sales of fiducial markers increased at 10.3% CAGR.
Fiducial Markers Market